EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pain in individuals with idiopathic inflammatory myopathies, other systemic autoimmune rheumatic diseases, and without rheumatic diseases: A report from the COVAD study

Samuel Katsuyuki Shinjo, Minchul Kim, Leonardo Santos Hoff, Rafael Giovani Missé, Parikshit Sen, R Naveen iD, Jessica Day, Rafael Alves Cordeiro, Jucier Gonçalves Júnior, Tulika Chatterjee, James B Lilleker, Vishwesh Agarwal und 23 weitere

International Journal of Rheumatic Diseases · 2023

DOI: 10.1111/1756-185x.14636 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Rheumatic Diseases, 2023. Verfasst von Samuel Katsuyuki Shinjo und 34 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil. Hauptthemen laut MEDLINE: COVID-19, Myositis, Autoimmune Diseases, Rheumatic Diseases. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To compare pain intensity among individuals with idiopathic inflammatory myopathies (IIMs), other systemic autoimmune rheumatic diseases (AIRDs), and without rheumatic disease (wAIDs).

Methods

Data were collected from the COVID‐19 Vaccination in Autoimmune Diseases (COVAD) study, an international cross‐sectional online survey, from December 2020 to August 2021. Pain experienced in the preceding week was assessed using numeral rating scale (NRS). We performed a negative binomial regression analysis to assess pain in IIMs subtypes and whether demographics, disease activity, general health status, and physical function had an impact on pain scores.

Results

Of 6988 participants included, 15.1% had IIMs, 27.9% had other AIRDs, and 57.0% were wAIDs. The median pain NRS in patients with IIMs, other AIRDs, and wAIDs were 2.0 (interquartile range [IQR] = 1.0–5.0), 3.0 (IQR = 1.0–6.0), and 1.0 (IQR = 0–2.0), respectively ( P < 0.001). Regression analysis adjusted for gender, age, and ethnicity revealed that overlap myositis and antisynthetase syndrome had the highest pain (NRS = 4.0, 95% CI = 3.5–4.5, and NRS = 3.6, 95% CI = 3.1–4.1, respectively). An additional association between pain and poor functional status was observed in all groups. Female gender was associated with higher pain scores in almost all scenarios. Increasing age was associated with higher pain NRS scores in some scenarios of disease activity, and Asian and Hispanic ethnicities had reduced pain scores in some functional status scenarios.

Conclusion

Patients with IIMs reported higher pain levels than wAIDs, but less than patients with other AIRDs. Pain is a disabling manifestation of IIMs and is associated with a poor functional status.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19MyositisAutoimmune DiseasesRheumatic DiseasesHumansFemaleCross-Sectional StudiesCOVID-19 VaccinesAutoantibodies

Stichwörter der Autor:innen

autoimmune diseasesfunctional statusmyositispainrheumatic diseases

Substanzen

COVID-19 VaccinesAutoantibodies

Autor:innen und Institutionen

  • Division of Rheumatology, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil.
  • Center for Outcomes Research, Department of Internal Medicine, University of Illinois College of Medicine Peoria, Peoria, Illinois, USA.
  • School of Medicine, Universidade Potiguar (UnP), Natal, Brazil.
  • Maulana Azad Medical College, New Delhi, India.
  • Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
  • Department of Rheumatology, Royal Melbourne Hospital, Melbourne, Victoria, Australia.

ORCID-Profile: R Naveen, Sinan Kardes, Tamer Gheita, Ioannis Parodis, Albert Selva O'Callaghan, Miguel A Saavedra, Nelly Ziade, Vikas Agarwal, Latika Gupta

Zitieren

APA

Shinjo, S. K., Kim, M., Hoff, L. S., Missé, R. G., Sen, P., Naveen, R., Day, J., Cordeiro, R. A., Júnior, J. G., Chatterjee, T., Lilleker, J. B., Agarwal, V., Kardes, S., Milchert, M., Gheita, T., Salim, B., Velikova, T., Gracia-Ramos, A. E., Parodis, I., …, & COVAD Study Group (2023). Pain in individuals with idiopathic inflammatory myopathies, other systemic autoimmune rheumatic diseases, and without rheumatic diseases: A report from the COVAD study. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.14636

Vancouver

Shinjo SK, Kim M, Hoff LS, Missé RG, Sen P, Naveen R, et al. Pain in individuals with idiopathic inflammatory myopathies, other systemic autoimmune rheumatic diseases, and without rheumatic diseases: A report from the COVAD study. International Journal of Rheumatic Diseases. 2023. doi:10.1111/1756-185x.14636

BibTeX
@article{Shinjo2023,
  author = {Shinjo, Samuel Katsuyuki and Kim, Minchul and Hoff, Leonardo Santos and Missé, Rafael Giovani and Sen, Parikshit and Naveen, R and Day, Jessica and Cordeiro, Rafael Alves and Júnior, Jucier Gonçalves and Chatterjee, Tulika and Lilleker, James B and Agarwal, Vishwesh and Kardes, Sinan and Milchert, Marcin and Gheita, Tamer and Salim, Babur and Velikova, Tsvetelina and Gracia-Ramos, Abraham Edgar and Parodis, Ioannis and O'Callaghan, Albert Selva and Nikiphorou, Elena and Makol, Ashima and Tan, Ai Lyn and Cavagna, Lorenzo and Saavedra, Miguel A and Ziade, Nelly and Knitza, Johannes and Kuwana, Masataka and Nune, Arvind and Distler, Oliver and Chinoy, Hector and Agarwal, Vikas and Aggarwal, Rohit and Gupta, Latika and COVAD Study Group, COVAD Study Group},
  title = {Pain in individuals with idiopathic inflammatory myopathies, other systemic autoimmune rheumatic diseases, and without rheumatic diseases: A report from the COVAD study},
  journal = {International Journal of Rheumatic Diseases},
  year = {2023},
  doi = {10.1111/1756-185x.14636}
}
Kostenlos starten →